Ico Therapeutics Company Profile (OTCMKTS:ICOTF)

About Ico Therapeutics

Ico Therapeutics logoiCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: ICOTF
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • 52-Week Range: $84,457,000.00 - $0.01
  • Trailing P/E Ratio:
  • P/E Growth:
  • Market Cap: $
  • Outstanding Shares: 84,457,000
  • Beta: 1.55
  • Return on Equity: -50.09%
  • Return on Assets: -48.83%
  • Current Ratio: 27.00%
  • Quick Ratio: 27.00%
Additional Links:
Companies Related to Ico Therapeutics:

Analyst Ratings

Consensus Ratings for Ico Therapeutics (OTCMKTS:ICOTF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Ico Therapeutics (OTCMKTS:ICOTF)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Ico Therapeutics (OTCMKTS:ICOTF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/2/2014($0.01)($0.01)ViewN/AView Earnings Details
5/30/2014($0.02)($0.01)ViewN/AView Earnings Details
4/28/2014($0.02)($0.02)ViewN/AView Earnings Details
11/27/2013Q3($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Ico Therapeutics (OTCMKTS:ICOTF)
No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Ico Therapeutics (OTCMKTS:ICOTF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ico Therapeutics (OTCMKTS:ICOTF)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Ico Therapeutics (OTCMKTS:ICOTF)
publicnow.com logoiCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders (OTCMKTS:ICOTF)
www.publicnow.com - July 12 at 8:33 AM
finance.yahoo.com logoiCo Therapeutics Announces Voting and Election Results from Annual Meeting of Shareholders (OTCMKTS:ICOTF)
finance.yahoo.com - June 27 at 4:46 PM
finance.yahoo.com logoICO THERAPEUTICS INC Financials (OTCMKTS:ICOTF)
finance.yahoo.com - June 8 at 1:04 PM


Ico Therapeutics (OTCMKTS:ICOTF) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by MarketBeat.com Staff